MBX — Microbix Biosystems Balance Sheet
0.000.00%
Last trade - 00:00- CA$29.88m
- CA$24.54m
- CA$18.59m
- 56
- 65
- 27
- 49
Annual balance sheet for Microbix Biosystems, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 9.99 | 13.5 | 11.6 | 13 | 12.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.21 | 3.09 | 4.18 | 4.19 | 1.61 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 19.1 | 22.4 | 22.3 | 24.3 | 23.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.08 | 8.91 | 8.93 | 9.62 | 10.1 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 28.8 | 33.1 | 35.7 | 38.1 | 37.4 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.19 | 2.65 | 4.35 | 3.39 | 2.78 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.3 | 8.21 | 11 | 9.8 | 9.62 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 18.6 | 24.9 | 24.6 | 28.3 | 27.8 |
| Total Liabilities & Shareholders' Equity | 28.8 | 33.1 | 35.7 | 38.1 | 37.4 |
| Total Common Shares Outstanding |